A Phase 1/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamis and Efficacy of VT-464 in Patients with Advanced Breast Cancer

Type of Cancer
Breast Oncology

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 1/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamis and Efficacy of VT-464 in Patients with Advanced Breast Cancer

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.